Development of a DNA microarray for toxicology based on hepatotoxin-regulated sequences

Environmental Health Perspectives

Volumn 111, Issue 1 T, 2003, Pages 53-60

  Waring, Jeffrey F ^a   Cavet, Guy ^b   Jolly, Robert A ^a   McDowell, Jeff ^a   Dai, Hongye ^b   Ciurlionis, Rita ^a   Zhang, Chunsheng ^b   Stoughton, Roland ^b   Lum, Pek ^b   Ferguson, Allan ^b   Roberts, Christopher J ^b   Ulrich, Roger G ^a  

^a ABBOTT LABORATORIES   (United States)

^b ROSETTA INPHARMATICS   (United States)

Author keywords

3 methylcholanthrene; Aroclor; Cyclopropane carboxylic acid; Hybridization kinetics; Microarray; Toxicogenomics; Toxicology

Indexed keywords

2,4 DINITROPHENOL; 3 METHYLCHOLANTHRENE; ACETYLSALICYLIC ACID; AFLATOXIN B1; ALCOHOL; ALLOPURINOL; ALLYL ALCOHOL; AMIODARONE; AROCLOR 1242; ARSENIC; BEZAFIBRATE; CARBAMAZEPINE; CARBON TETRACHLORIDE; CHLORPROMAZINE; CYCLOPHOSPHAMIDE; CYCLOPROPANECARBOXYLIC ACID DERIVATIVE; DACTINOMYCIN; DEXAMETHASONE; DICLOFENAC; DIQUAT; DOXORUBICIN; ERYTHROMYCIN; ETOPOSIDE; IBUPROFEN; INDOMETACIN; PARACETAMOL; TROVAFLOXACIN; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL;

ANIMAL TISSUE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA LIBRARY; DNA MICROARRAY; DNA PROBE; DNA SEQUENCE; GENE CONTROL; GENE EXPRESSION; LIVER FUNCTION; LIVER TOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALIA;

EID: 0037261485     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/txg.5998     Document Type: Review

References (59)

1. Adams, SS, McCullough KF, Nicholson JS. 1969. The pharmacological properties of ibuprofen, and anti-inflammatory, analgesic and antipyretic agent. Arch Int Pharmacodyn 6:119-129.
2. Altschul SF, Boguski MS, Gish W, Wootton JC. 1994. Issues in searching molecular sequence databases. Nature Genet 6:119-129.
3. Altschul SF, Madden TL, Sch⊣affer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389-3402.
4. Bader M, Thrum H, Guttner J, Klinger W. 19974. Actinomycin D: Toxicity, liver functions and morphological findings in rats. Acta Biol Med Ger 32:91-98.
5. Beier K, Volki A, Hashimoto T, Fahimi HD. 1988. Selective induction of peroxisomal enzymed by the hypolipidemic drug bezafibrate. Detection of modulations by automatic image analysis in conjunction with immunoelectron microscopy and immunoblotting. Eur J Cell Biol 46:383-393.
6. Borlak J, Thum T. 2001. Induction of nuclear transcription factors, cytochrome P450 monooxygenesis, and glutathione S-transferase α gene expression in Aroclor 1254-treated rat hepatocyte cultures. Biochem Pharmacol 61:145-153.
7. Borlakoglu JT, Edwards-Webb JD, Dils RR. 1991. Evidence for the induction of fatty acid desaturation in proliferating hepatic endoplasmic reticulum in response to treatment with polychlorinated biphenyls. Are fatty acid desaturases cytochrome P-450 dependent monooxygenases? Int J Biochem 23:925-931.
8. Brown PA, Thomson AW, Whitting PH, Davidson RJ, Simpson JG. 1985. Immunosuppressive activity and toxicity of cyclosporin A in rats pretreated with high dose cyclophosphamide. Agents Actions 17:67-72.
9. Bulera SJ, Eddy SM, Ferguson E, Jatkoe TA, Reidel JF, Bleavins MR, et al. 2001. RNA expression in the early characteristics of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 33:1239-1258.
10. Chisholm JW, Dolphin PJ. 1996. Abnormal lipoproteins in the ANIT-treated rat: a transient and reversible animal model of intrahepatic cholestasis. J Lipid Res 37:1086-1098.
11. Custer RP, Freeman-Narrod M, Narrod SA. 1977. Hepatotoxicity in Wistar rats following chronic methotrexate administration: a model of human reaction. J Natl Cancer Inst 58:1011-1017.
12. Dai H, Meyer M, Stepaniants S, Ziman M, Stoughton R. 2002. Use of hybridization kinetics for differentiating specific from non-specific binding to oligonucleotide microarrays. Nucleic Acids Res 30:e86.
13. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, et al. 1996. Suppression subractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A 93:6025-6030.
14. Dini L, Giudetti AM, Ruzittu M, Gnoni GV, Zara V. 1999. Citrate carrier and lipogenic enzyme activities in lead nitrate-induced proliferative and apoptotic phase in rat liver. Biochem Mol Biol Int 47:607-614.
15. Fracasso ME, Cuzzolin L, Soldato PD, Leone R, Velo GP, Benoni G. 1987. Multisystem toxicity of indomethacin: effects on kidney, liver and intestine in the rat. Agents Actions 22:310-313.
16. Ganey PE, Schultze AE. 1995. Depletion of neutrophils and modulation of Kupffer cell function in allyl alcohol-induced hepatotoxicity. Toxicology 1-2:99-106.
17. Garzon De la Mora P, Garcia-Estrada J, Navarro-Ruiz A, Roman-Maldonado S, Bastidas-Ramirez BE, Gonzalez-Hita M, et al. 1990. Oral administration of diphenylhydantoin sodium (DFH-Na or phenytoin) predictably affects the liver and kidney of Sprague Dawley rats. Arch Invest Med (Mex) 21:339-347.
18. Gerhold D, Rushmore T, Caskey CT. 1999. DNA chips: promising toys have become powerful tools. Trends Biochem 24: 168-173.
19. Graichen ME, Neptun DA, Dent JG, Popp JA, Leonard TB. 1985. Effects of methapyrilene on rat hepatic xenobiotic metabolizing enzymes and liver morphology. Fundam Appl Toxicol 1:165-174.
20. Hamadeh HK, Bushel PR, Jayadev S, DiSorbo O, Bennett L, Li L, et al. 2002a. Prediction of compound signature using high density gene expression profiling. Toxicol Sci 67:232-240.
21. Hamadeh HK, Bushel PR, Jayadev S, Martin K, DiSorbo O, Sieber S, et al. 2002b. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 67:219-231.
22. Heel RC, Brogden RN, Carmine A, Morley PA, Speight TM, Avery GS. 1982. Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs 23:1-36.
23. Holden PR, James NH, Brooks AN, Roberts RA, Kimber I, Pennie WD. 2000. Identification of a possible association between carbon tetrachloride-induced hepatotoxicity and interleukin-8 expression. J Biochem Mol Toxicol 14:283-290.
24. Hughes TR, Mao M, Jones AR, Burchard J, Marton MJ, Shannon KW, et al. 2001. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol 19:342-347.
25. Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, et al. 2000. Functional discovery via a compendium of expression profiles. Cell 102:109-126.
26. Jauregui HO, Ng SF, Gann KL, Waxman DJ. 1991. Xenobiotic induction of P-450 PB-4 (IIB1) and P-450c (IA1) and associated monooxygenase activities in primary cultures of adult rat hepatocytes. Xenobiotica 21:1091-1106.
27. Kaikaus RM, Chan WK, Montellano PR, Bass NM. 1993. Mechanisms of regulation of liver fatty acid-binding protein. Mol Cell Biochem 123:93-100.
28. Kaltiala EH, Rasanen O, Herva E, Karki NT. 1967. Subchronic toxicity of some erthromycin compounds in rats. Acta Pharmacol Toxicol (Copenh) 25:435-446.
29. Kesterson JW, Granneman GR, Machinist JM. 1984. The hepatotoxicity of valproic acid and its metabolites in rats. Toxicologic, biochemical and histophatologic after 3-methylcholanthrene pretreatment. Acta Biol Med Ger 710:1701-1705.
30. Kramar R, Hohenegger M, Srour AN, Khanakah G. 1984. Oligomycin toxicity in intact rats. Agents Actions 15:660-663.
31. Landon EJ, Naukam RJ, Sastry BVR. 1986. Effects of calcium channel blocking agents on calcium and centrilobular necrosis in the liver of rats treated with hepatotoxic agents. Biochem Pharmacol 35:697-705.
32. Lettinga KD, Gutter W, VanNoorden CJ, Schellens JP, Frederiks WM. 1996. Early effects of high doses of retinol (vitamin A) on the in situ cellular metabolism in rat liver. Liver 16:1-11.
33. Linden CJ. 1989. Toxicity of interperitoneally administered antitumor drugs in athymic rats. In Vivo 3:259-262.
34. Lubert RA, Jones CR, Stockus DL, Fox SD, Nims RW. 1991. Introduction of cytochrome P450 and other drug-metabolizing enzymes in rat liver following dietary exposure to Aroclor 1254. Toxicol Appl Pharmacol 108:355-365.
35. Mahaffey KR, Capar SG, Gladen BC, Fowler BA. 1981. Concurrent exposure to lead, cadmium, and arsenic. Effects on toxicity and tissue metal concentrations in the rat. J Lab Clin Med 98:463-481.
36. Makalowski W, Boguski MS. 1998. Evolutionary parameters of the transcribed mammalian genome: an analysis of 2,820 orthologous rodent and human sequences. Proc Natl Acad Sci U S A 95:9407-9412.
37. Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Meyer MR, Roberts CJ, et al. 1998. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 4:1293-1301.
38. Mathew T, Karunanithy R, Yee MH, Natarajan PN. 1980. Hepatotoxicity of dimethylformamide and dimethylsulfoxide at and above the levels used in some aflatoxin studies. Lab Invest 42:257-262.
39. Mehlman MA, Tobin RB, Friend B, Mackerer CR. 1975. The effects of a polychlorinated biphenyl mixture (Aroclor 1254) on liver gluconeogenic enzymes of normal and alloxan-diabetic rats. Toxicology 5:89-95.
40. Mkrtchian S, Fang C, Hellman U, Ingelman-Sundberg M. 1998. A stress-inducible rat liver endoplasmic reticulum protein, ERp29. Eur J Biochem 251:304-313.
41. Perazzo J, Eizayaga F, Romay S, Bengochea L, Pavese A, Lemberg A. 1999. An experimental model of liver damage and portal hypertension induced by a single dose of monocrotaline. Hepatogastroenterology 46:432-435.
42. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. 2001. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811-7819.
43. Reasor MJ, McCloud CM, Beard TL, Ebert DC, Kacew S, Gardner MF, et al. 1996. Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats. Toxicology 106:139-147.
44. Regnaud L, Sirois G, Chakrabarti S. 1988. Effect of four-day treatment with carbamazepine at different dose levels on microsomal enzyme induction, drug metabolism and drug toxicity. Pharmacol Toxicol 62:3-6.
45. Reilly TP, Bourdi M, Brady JN, Pise-Masison CA, Radonovich MF, George JW, et al. 2001. Expression profiling of acetaminophen liver toxicity in mice using microarray technology. Biochem Biophys Res Commun 282:321-328.
46. Root M, Lange T, Campbell TC. 1997. Dissimilarity in aflatoxin dose-response relationships between DNA adduct formation and development of pre-neoplastic foci in rat liver. Chem Biol Interact 106:213-227.
47. Saarikoski ST, Ikonen TS, Oinonen T, Lindros KO, Ulmanen I, Husgafvel-Pursiainen K. 1998. Induction of UDP-glycosyltransferase family 1 genes in rat liver: different patterns of mRNA expression with two inducers, 3-methyl-cholanthrene and β-naphthoflavone. Biochem Pharmacol 56:569-575.
48. Smith GS, Nadig DE, Kokoska ER, Solomon H, Tiniakos DG, Miller TA. 1998. Role of neutrophils in hepatotoxicity induced by oral acetaminophen administration in rats. J Surg Res 80:252-258.
49. Smith TF, Waterman MS. 1981. Comparison of bio-sequences. Adv in App Math 2:482-489.
50. Speisky H, Bunout D, Orrego H, Giles HG, Gunasekara A, Israel Y. 1985. Lack of changes in diene conjugate levels following ethanol induced glutathione depletion or hepatic necrosis. Res Commun Chem Pharmacol 48:77-90.
51. Thomas RS, Rank DR, Penn SG, Zastrow GM, Hayes KR, Pande K, et al. 2001. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol 60:1189-1194.
52. Ulrich RG, Bacon JA, Cramer CT, Petrella D, Sun EL, Meglasson MD, et al. 1998. Disruption of mitochondrial activities in rabbit and human hepatocytes by a quinoxalinone anxiolytic and its carboxyic acid metabolite. Toxicology 131:33-47.
53. Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG. 2001a. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 120:359-368.
54. Waring JF, Jolly RA, Ciurlionis R, Lum PY, Praestgaard JT, Morfitt DC, et al. 2001b. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol 175:28-42.
55. Williams GM, Iatropoulos MJ, Wang CX, Ali N, Rivenson A, Peterson LA, et al. 1996. Diethylnitrosamine exposure-responses for DNA damage, centrilobular cytotoxicity, cell proliferation and carcinogenesis in rat liver exhibit some nonlinearities. Carcinogenesis 10:2253-2258.
56. Wogan GN. 1997. Review of the toxicology of tamoxifen. Semin Oncol 24:S1-S87.
57. Wolfgang GH, Donarski WJ, Petry TW. 1990. Effects of novel antioxidants on carbon tetrachloride-induced lipid peroxidation and toxicity in precision-cut rat liver slices. Toxicol Appl Pharmacol 106:63-70.
58. Wolfgang GH, Jolly RA, Petry TW. 1991. Diquat-induced oxidative damage in hepatic microsomes: effects of antioxidants. Free Radic Biol Med 10:403-411.
59. Younes M, Eberhardt I, Lemoine R. 1989. Effect of iron overload on spontaneous and xenobiotic-induced lipid peroxidation in vivo. J Appl Toxicol 9:103-108.